Arkolith/Insider Trading/LYEL/Form 4

Klausner Richard

DirectorLyell Immunopharma, Inc. (LYEL) · full profile →Form 4 · filed Mar 18, 2025
Net Buying
Open-Market Buys
$95K
Open-Market Sells
$0
Net Open-Market Flow
$95K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 14, 2025Buy(P)158K$0.60$95K843K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-008540) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML